BMS 200 mg 3631
Generic Name: atazanavir
Pill imprint BMS 200 mg 3631 has been identified as Reyataz 200 mg.
Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy.
Reyataz 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Reyataz Images
- Generic Name:
- atazanavir
- Imprint:
-
BMS 200 mg
3631 - Strength:
- 200 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-3631
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4854 | Physicians Total Care Inc (repackager) |
| 54569-5532 | A S Medication Solutions LLC (repackager) |
| 35356-0207 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Reyataz resources
Search Again
